Novavax, Inc. (LON:0A3S)
London · Delayed Price · Currency is GBP · Price in USD 7.68
-0.38 (-4.70%)
At close: Nov 4, 2025
Novavax Market Cap
Novavax has a market cap or net worth of 957.81 million as of November 6, 2025. Its market cap has decreased by -23.36% in one year.
Market Cap
957.81M
Enterprise Value
663.49M
Revenue
787.36M
Ranking
n/a
PE Ratio
3.10
Stock Price
7.68
Market Cap Chart
Since July 25, 1996, Novavax's market cap has increased from 22.60M to 957.81M, an increase of 4,138.15%. That is a compound annual growth rate of 13.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 957.81M | -6.89% |
| Dec 31, 2024 | 1.03B | 129.81% |
| Dec 29, 2023 | 447.65M | -38.98% |
| Dec 30, 2022 | 733.56M | -90.82% |
| Dec 31, 2021 | 7.99B | 167.41% |
| Dec 31, 2020 | 2.99B | 4,139.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.27B |
| HSBC Holdings | 184.59B |
| Shell | 164.07B |
| Unilever | 115.32B |
| Rolls-Royce Holdings | 96.56B |
| Rio Tinto Group | 90.02B |
| British American Tobacco p.l.c. | 88.16B |
| GSK plc | 71.94B |